Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management impacts on the dissolved organic carbon release from deadwood, ground vegetation and the forest floor in a temperate Oak woodland.

The Science of the total environment·2021
Same author

Appropriate use of noninvasive ischemia testing to guide revascularization decision making following acute ST elevation myocardial infarction in Latin American countries: Results from an expert panel meeting of the International Atomic Energy Agency.

Revista espanola de medicina nuclear e imagen molecular·2018
Same author

Adsorption of Pb and Zn from binary metal solutions and in the presence of dissolved organic carbon by DTPA-functionalised, silica-coated magnetic nanoparticles.

Chemosphere·2017
Same author

HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.

HIV medicine·2015
Same author

Does ochre have the potential to be a remedial treatment for As-contaminated soils?

Environmental pollution (Barking, Essex : 1987)·2015
Same author

International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries.

International journal of cardiology·2014

Related Experiment Video

Updated: May 12, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Risk stratification after myocardial infarction

E D Peterson1, L J Shaw, R M Califf

  • 1Duke University Medical Center, Durham, North Carolina, USA.

Annals of Internal Medicine
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Early risk stratification after acute myocardial infarction is crucial. Continuous reassessment of patient risk during hospitalization optimizes outcomes and manages costs effectively.

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

Related Experiment Videos

Last Updated: May 12, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Prognosis

Background:

  • Acute myocardial infarction (AMI) management has evolved with reperfusion therapies.
  • Effective risk stratification is essential for guiding treatment decisions and improving patient outcomes.
  • The reperfusion era necessitates updated strategies for assessing prognosis post-AMI.

Purpose of the Study:

  • To conduct a literature review on risk stratification methods following acute myocardial infarction in the reperfusion era.
  • To develop a proposed algorithm for early and ongoing risk assessment in AMI patients.
  • To provide evidence-based recommendations for clinical practice.

Main Methods:

  • Comprehensive MEDLINE search of English-language human studies (1981-1996) using terms: myocardial infarction, prospective studies, prognosis.
  • Supplemented with targeted searches for subheadings (e.g., cardiogenic shock, thrombolytic therapy, stress testing).
  • Synthesized observational data and clinical judgment due to limited randomized trials for direct comparison of risk-stratification methods.

Main Results:

  • Risk stratification should commence immediately upon diagnosis of acute myocardial infarction.
  • Rapid identification of high-risk patients (e.g., cardiogenic shock) and reperfusion candidates is vital for timely intervention.
  • Specialized tests during hospitalization can provide incremental value for risk assessment.
  • High-risk patients with post-infarction complications or left ventricular dysfunction may benefit from early angiography.
  • Low-risk patients without these complications should undergo noninvasive stress testing for further risk stratification.

Conclusions:

  • Continuous risk reappraisal throughout hospitalization is recommended for physicians.
  • Optimizing patient outcomes and achieving cost containment are key benefits of ongoing risk assessment.
  • An integrated approach to risk stratification improves the management of patients post-myocardial infarction.